Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation*-Reference-Cited by-同舟云学术

Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation*

Published:2009-07 Issue:7 Volume:37 Page:2174-2179
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Siu Chung-Wah,Lau Chu-Pak,Lee Wai-Luen,Lam Kwok-Fai,Tse Hung-Fat

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference39 articles.

1. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

2. Increasing US Emergency Department Visit Rates and Subsequent Hospital Admissions for Atrial Fibrillation from 1993 to 2004

3. A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation

4. A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation

5. Management of Newly Detected Atrial Fibrillation: A Clinical Practice Guideline from the American Academy of Family Physicians and the American College of Physicians

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety and efficacy of a hybrid intravenous and oral diltiazem protocol for acute rate control in the emergency department;The American Journal of Emergency Medicine;2024-10

2. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

3. A Comparison of the Impact of Pharmacological Treatments on Cardioversion, Rate Control, and Mortality in Data-Driven Atrial Fibrillation Phenotypes in Critical Care;Bioengineering;2024-02-20

4. Safety and Effectiveness of Antidysrhythmic Drugs for Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation: a Systematic Review and Bayesian Network Meta-analysis;Cardiovascular Drugs and Therapy;2024-02-07

5. Atrial fibrillation: better symptom control with rate and rhythm management;The Lancet Regional Health - Europe;2024-02